Cost-Effectiveness Analysis of Prophylactic Cervical Cancer Vaccination in Japanese Women
Open Access
- 1 April 2010
- journal article
- research article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 20 (3) , 385-392
- https://doi.org/10.1111/igc.0b013e3181d189b8
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Comparison of detailed and succinct cohort modelling approaches in a multi-regional evaluation of cervical cancer vaccinationVaccine, 2008
- How Much Are Americans Willing to Pay for a Quality-Adjusted Life Year?Medical Care, 2008
- Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis updateInternational Journal of Cancer, 2007
- Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseasesVaccine, 2006
- The evaluation of human papillomavirus DNA testing in primary screening for cervical lesions in a large Japanese populationInternational Journal of Gynecologic Cancer, 2006
- Sexual behaviour and high risk human papillomavirus infections in Japanese womenSexually Transmitted Infections, 2005
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003
- Human papillomavirus is a necessary cause of invasive cervical cancer worldwideThe Journal of Pathology, 1999
- Toward Consistency in Cost-Utility AnalysesMedical Care, 1998
- Type of human papillomavirus is related to clinical features of cervical carcinomaCancer, 1996